Kiora Pharmaceuticals Inc... (KPRX)
3.25
-0.10 (-3.10%)
At close: Feb 28, 2025, 3:59 PM
3.25
0.00%
After-hours: Feb 28, 2025, 04:00 PM EST
Kiora Pharmaceuticals Cash Flow Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| Net Income | -12.51M | -13.58M | -16.39M | -8.09M | -7.1M | -10.81M | -13.22M | -13.34M | -8.39M | -1.55M | -3.68M | -5.81M |
| Depreciation & Amortization | 62.42K | 41.61K | 45.3K | 33.4K | 213.93K | 38.48K | 19.29K | 5.18K | 1.26K | 1.72K | 5.46K | 9.09K |
| Stock-Based Compensation | 754.94K | 462.45K | 842.48K | 723.86K | 852.23K | 875.29K | 870.31K | 511K | 1.22M | 26.82K | 184.03K | 396.38K |
| Other Working Capital | -1.01M | -113.95K | -725.13K | -457.91K | -2.87M | -390.47K | 7.82M | 3.7M | 1.91M | 928.6K | 98.27K | 149.71K |
| Other Non-Cash Items | 3.87M | 2.1M | 5.96M | 326.67K | 500K | 2.28M | 91.05K | 511K | 1.68M | -1.11M | 533.27K | 5.12K |
| Deferred Income Tax | 90.32K | -113.01K | -304.78K | 12.05K | 95.4K | 86.05K | -1.34M | -511K | n/a | 200.76K | n/a | n/a |
| Change in Working Capital | -1.82M | 668.51K | -1.04M | -321.21K | -2.72M | -1.03M | 7.11M | 4.41M | 1.02M | 1.48M | 2.22K | 175.89K |
| Operating Cash Flow | -9.56M | -10.43M | -10.89M | -7.32M | -8.15M | -10.84M | -6.47M | -8.41M | -4.46M | -950.62K | -2.96M | -5.22M |
| Capital Expenditures | 1.00 | n/a | -63.87K | -133.79K | n/a | -270K | -37K | -11K | n/a | n/a | n/a | n/a |
| Acquisitions | n/a | 6.38K | -93.16K | -110.64K | n/a | n/a | n/a | 185.75K | n/a | n/a | n/a | n/a |
| Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -20K | n/a | n/a | n/a |
| Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | n/a | 6.38 | 0.00 | -113.72 | n/a | -250 | n/a | -25K | -20K | n/a | n/a | n/a |
| Investing Cash Flow | n/a | 6.38K | -157.02K | -244.44K | n/a | -270K | -37K | 149.75K | -20K | n/a | n/a | n/a |
| Debt Repayment | n/a | n/a | -212.28K | 278.19K | n/a | n/a | n/a | -2.86K | n/a | 1.76M | 1.46M | 34.2K |
| Common Stock Repurchased | n/a | -15.63K | n/a | n/a | -2.61K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | -187.92K | 3.26M | 50K | -280.69K | 2.05M | 1.2M | 82.17K | -267.61K | -1.49M | -1.14M | 1.32K | -109.6K |
| Financial Cash Flow | 5.97M | 8.62M | 17.8M | 5M | 3.92M | 11.3M | 10.67M | 3.5M | 12.62M | 613.27K | 1.46M | -75.41K |
| Net Cash Flow | -3.55M | -1.89M | 6.67M | -2.59M | -4.23M | 198.21K | 4.17M | -4.76M | 8.23M | -334.17K | -1.47M | -5.3M |
| Free Cash Flow | -9.56M | -10.43M | -10.95M | -7.45M | -8.15M | -11.11M | -6.51M | -8.42M | -4.46M | -950.62K | -2.96M | -5.22M |